Long-acting insulin and use thereof
US10253082B2 · kind B2 · utility
0Cited by
13References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 20, 2015 |
| Grant date | Apr 9, 2019 |
| Priority date | — |
| Expiry date | Jan 20, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an insulin analog that has reduced insulin receptor binding affinity for the purpose of increasing the blood half-life of insulin, and long-acting insulin, a conjugate, and a method of preparing long-acting insulin using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.